http://orcid.org/0000-0001-9919-1043
References
- Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477–482.e1.
- Morris BH, Oh W, Tyson JE, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med. 2008;359(18):1885–1896.
- Oh W, Stevenson DK, Tyson JE, et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants. Acta Paediatr. 2010;99(5):673–678.
- Pediatrics AAo. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316.
- Newman TB, Kuzniewicz MW, Liljestrand P, et al. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines. Pediatrics. 2009;123(5):1352–1359.
- van der Schoor LW, Dijk PH, Verkade HJ, et al. Unconjugated free bilirubin in preterm infants. Early Hum Dev. 2017;106–107:25–32.
- Watchko JF, Maisels MJ. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F455–F458.
- Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics. 1982;69(4):481–485.
- Funato M, Tamai H, Shimada S, et al. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics. 1994;93(1):50–53.
- Ahlfors CE, Wennberg RP, Ostrow JD, et al. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55(7):1288–1299.
- Amin SB, Saluja S, Saili A, et al. Auditory toxicity in late preterm and term neonates with severe jaundice. Dev Med Child Neurol. 2017;59(3):297–303.
- Huber AH, Zhu B, Kwan T, et al. Fluorescence sensor for the quantification of unbound bilirubin concentrations. Clin Chem. 2012;58(5):869–876.
- Hegyi T, Kleinfeld A, Huber A, et al. Effects of soybean lipid Infusion on unbound free fatty acids and unbound bilirubin in preterm infants. J Pediatr. 2017;184:45–50.e1.
- Oh W, Tyson JE, Fanaroff AA, et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics. 2003;112(4):773–779.
- Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354(18):1889–1900.
- Okumura A, Kidokoro H, Shoji H, et al. Kernicterus in preterm infants. Pediatrics. 2009;123(6):e1052–e1058:e1052-8.
- Kim MH, Yoon JJ, Sher J, et al. Lack of predictive indices in kernicterus: a comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics. 1980;66(6):852–858.
- Ahlfors CE, Parker AE. Bilirubin binding contributes to the increase in total bilirubin concentration in newborns with jaundice. Pediatrics. 2010;126(3):e639–e643.
- Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage – mechanisms and management approaches. N Engl J Med. 2013;369(21):2021–2030.
- Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage. N Engl J Med. 2014;370(10):979.
- Huber AH, Hegyi T, Kleinfeld AM Free fatty acids produced from intralipid and sulfisoxazole displace similar amounts of bilirubin from albumin. Vancouver, CA: Pediatric Academic Societies; 2014.
- Jacobsen J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns. Clin Chem. 1974;20(7):783.
- Wennberg RP. Measuring free bilirubin: the clinical perspective. Clin Chem. 2012;58(5):811–813.
- Amin SB, Harte T, Scholer L, et al. Intravenous lipid and bilirubin-albumin binding variables in premature infants. Pediatrics. 2009;124(1):211–217.